Cell-based therapies offer promise for patients with
Parkinson's disease (PD); however, durable and effective
transplantation substrates need to be defined. This study characterized the feasibility and growth properties of primary cultures established from small-volume brain biopsies taken during
deep brain stimulation (DBS) surgery in patients with PD. The lineage and expression of
neurotrophic factors with known beneficial actions in PD-affected brain circuitry were also evaluated. Nineteen patients with PD undergoing DBS surgery consented to brain biopsies prior to
electrode implantation. Cultures from these samples exhibited exponential and plateau phases of growth and were readily expanded throughout multiple passages. There was robust expression of progenitor markers and the unexpected colocalization of neural and mesenchymal
proteins. The oligodendrocyte
transcription factor, Olig1, and the myelin-specific sphingolipid,
galactocerebroside, were coexpressed with each of glial-derived
neurotrophic factor, brain-derived neurotrophic factor, and cerebral
dopamine neurotrophic factor. Fluorescence-activated cell sorting demonstrated homogeneous expression of both
nestin and Olig1 throughout the expanded cultures. Cells remained viable after a year in cryostorage. These findings confirm the feasibility of small brain biopsies as an expandable source of autologous cell substrate in living patients and demonstrate the complex phenotype of these cells, with implications for therapeutic application in PD and other neurological diseases.